Late-Stage Studies of a Cancer-Drug Combination Fall Short in NSCLC Patients NewsbyAdministratorSeptember 22, 20231 minute readNo comments
Major Injury Blow for Dallas Cowboys Defense NewsbyAdministratorSeptember 22, 20232 minute readNo comments
U.S. Stock Futures Rebound After Fed’s Interest-Rate Forecast NewsbyAdministratorSeptember 22, 20232 minute readNo comments
News Fulgent Genetics Raises Full-Year Guidance and Reports Strong Q2 Results Shares of Fulgent Genetics surged in premarket trade following the company’s announcement of stronger-than-expected second-quarter results and an… byAdministratorAugust 6, 2023No comments
